(Q46736545)

English

Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

0 references

1 reference

based on heuristic

inferred from title

author name string

Savani BN

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Montero A

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Kurlander R

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Childs R

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Hensel N

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Barrett AJ

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

Bone Marrow Transplantation

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

36

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

1009-1015

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705167

0 references

Chronic myeloid leukemia-still a few questions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host dis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

21 January 2018

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

7 January 2021

based on heuristic

inferred from DOI database lookup

Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705167

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705167

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

release_cjk5ootjynfgvekteamujt4tgi

1 reference

https://api.fatcat.wiki/v0/release/cjk5ootjynfgvekteamujt4tgi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16205732

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46736545&oldid=2129083333"